Abstract:Background: Emerging evidence suggests that Eph/ephrin-system involves different facets of tumorigenesis and cancer progression. Whether ephrin-A3, a cognate ligand to several Eph receptors, plays a role in HCC cell proliferation and metastasis remains unclear. Methods: The expression of ephrin-A3 was detected by immunohistochemistry and qRT-PCR in human HCC tissues. The clinical significance of ephrin-A3 was analyzed using multiple databases. The biological functions of ephrin-A3 were investigated in vitro and in vivo. Immunofluorescence and co-immunoprecipitation were used to detect the interaction between ephrin-A3 and EphA2. Findings: Elevated expression of ephrin-A3 was positively correlated with the histological grade, metastasis and poor prognosis in human HCC. Knockdown of ephrin-A3 led to significantly decreased proliferative activity and metastatic potential, and re-introduction of ephrin-A3 rescued the decreased proliferation, migration, and invasion induced by ephrin-A3 knockdown in HCC cells. Ephrin-A3 interacted with EphA2 and positively regulated EphA2 and AKT phosphorylation. Knockdown of EphA2 attenuated HCC cell proliferation, migration, and invasion induced by ephrin-A3 overexpression. Furthermore, ephrin-A3-induced EphA2 phosphorylation is both a substrate and a positive regulator of AKT. In HCC tissues, ephrin-A3 expression was positively correlated with EphA2, and patients with high co-expression of ephrin-A3 and EphA2 exhibited poorer prognosis. Interpretation: Ephrin-A3 promotes HCC metastasis by interacting with EphA2 and activating EphA2 and AKT. Thus, our study implicates ephrin-A3 and EphA2 as potential prognostic biomarkers, and provides valuable information for HCC prognosis and treatment. Funding Statement: This work was supported in part by grants from the National Natural Science Foundation of China (81672832), Outstanding Subject Leader Training Program of Shanghai Municipal Commission of Health and Family Planning (2018BR20), the National Natural Science Foundation of Shanghai (20ZR1454000), the National Key Sci-Tech Special Project of China (2018ZX10723204-006), the Research Project of Shanghai Municipal Commission of Health and Family Planning (20204Y0093), and the Grants from the State Key Laboratory of Oncogenes and Related Genes (91-17-18). Declaration of Interests: The authors declare that they have no competing interests. Ethics Approval Statement: The study was approved by the Research Ethics Committee of Renji Hospital, Shanghai Jiao Tong University School of Medicine, and informed consent was obtained from each patient from the Zhejiang University (Hangzhou, China) and the Qidong Liver Cancer Institute (Qidong, China).

EphA4 Protein Promotes Invasion in Clear Cell Renal Cell Carcinomas.

Expression of the EphA1 Protein is Associated with Fuhrman Nuclear Grade in Clear Cell Renal Cell Carcinomas.

High Expression of EphA4 is Associated with Invasion and Lymph Node Metastasis in Colorectal Carcinomas.

EFNA3 is Involved in Immune Regulation and the Ras Signal Pathway in Hepatocellular Carcinoma

Loss of EphA3 Protein Expression is Associated with Advanced TNM Stage in Clear-Cell Renal Cell Carcinoma

Expression of EphA1 protein in clear cell renal cell carcinomas and its clinical significance

Decreased Expression of Receptor Tyrosine Kinase of EphB1 Protein in Renal Cell Carcinomas.

Ephrin-A3 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis by Interacting with EphA2

EphB4 Promotes the Proliferation, Invasion, and Angiogenesis of Human Colorectal Cancer.

Decreased Expression Of Epha5 Is Associated With Fuhrman Nuclear Grade And Pathological Tumour Stage In Ccrcc

EphA6 Promotes Angiogenesis and Prostate Cancer Metastasis and is Associated with Human Prostate Cancer Progression.

A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets

EphB 4 Gene Polymorphism and Protein Expression in Non-Small-cell Lung Cancer

Increased Expression of EphA1 Protein in Prostate Cancers Correlates with High Gleason Score.

Liver Cancer: Ephrina2 Promotes Tumorigenicity Through Rac1/Akt/Nf-Kappa B Signaling Pathway

High expression of eIF4A1 predicts unfavorable prognosis in clear cell renal cell carcinoma

The Expressions of EphB4 and Ephrinb2 in Lung Adenocarcinomas: a High Level of the EphB4 Protein is Associated with Lymph Node Metastasis.

Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer.

High Expression of EphA1 in Esophageal Squamous Cell Carcinoma is Associated with Lymph Node Metastasis and Advanced Disease

EphrinA3 is a Key Regulator of Malignant Behaviors and a Potential Prognostic Factor in Lung Adenocarcinoma

HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.